ISOThrive Inc.

First of its kind treatment for GERD, novel Mechanism of Action, completed proof of concept data, high return exit potential within 18-24 months

  • Stage Product In Market
  • Industry Biotechnology
  • Location Healdsburg, CA, USA
  • Currency USD
  • Founded November 2013
  • Employees 11
  • Incorporation Type C-corp
  • Website pharma.isothrive.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free